New York State Common Retirement Fund Adagio Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $74.6 Billion
- Q4 2024
A detailed history of New York State Common Retirement Fund transactions in Adagio Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 4,000 shares of ADGI stock, worth $13,240. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,000
Previous 4,000
-0.0%
Holding current value
$13,240
Previous $4,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ADGI
# of Institutions
76Shares Held
70.5MCall Options Held
3.6KPut Options Held
2.1K-
Lee Ainslie Maverick Capital LTD | Dallas, Tx11.8MShares$38.9 Million0.75% of portfolio
-
Mithril Ii Gp LP Austin, TX11.2MShares$37.2 Million30.95% of portfolio
-
Deep Track Capital, LP Greenwich, CT10.7MShares$35.4 Million1.56% of portfolio
-
M28 Capital Management LP Stamford, CT9.25MShares$30.6 Million24.88% of portfolio
-
Black Rock Inc. New York, NY4.47MShares$14.8 Million0.0% of portfolio
About Adagio Therapeutics, Inc.
- Ticker ADGI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 108,831,000
- Market Cap $505M
- Description
- Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...